Technology | April 01, 2014

AccessClosure Launches Next-Generation Vascular Closure Device at ACC.14

Innovative patient-friendly device combines safety of extravascular sealant and security of mechanical closure to provide consistent results

AccessClosure Next-Generation Vascular Closure Device ACC.14 March 2014

April 1, 2014 — AccessClosure Inc. commercially launched its Mynx Ace vascular closure device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites. [1] The device joins the pioneering line of Mynx extravascular products that help care teams reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures. The commercial launch was announced as part of the annual meeting of the American College of Cardiology.

Mynx closure devices are designed for patient comfort by providing gentle vascular closure without the use of cinching, sutures, or metal implants to enhance patient satisfaction and keep physicians on the leading edge of patient care. [2] With Mynx Ace, physicians can consistently close femoral artery access sites through a simple, three-step deployment system. The Mynx Ace system uses AccessClosure’s proprietary Grip Technology, a major advancement in sealant technology. Grip technology employs an extravascular sealant that actively adheres to the artery for safe and secure mechanical closure and dissolves within 30 days, leaving nothing behind in the healed vessel.

“After completing over 50 cases with Mynx Ace, I have found the system provides consistent results while offering the safety, security and patient-friendly advancements I have come to trust in Mynx products” said Rajesh Dave, M.D., a cardiologist from Holy Spirit Hospital in Camp Hill, PA. “The advancements have made Mynx Ace a preferred closure device in my practice.”

Mynx Ace can be used with patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5 French, 6 French or 7 French procedural sheath. It is estimated that more than 2.1 million of these procedures are conducted each year in the United States.

For more information: www.accessclosure.com

References:

1.    As compared to earlier generations of Mynx closure devices. Test data on file at AccessClosure.

2.    Fargen KM, Hoh Bl, Mocco J. J NeuroIntervent Surg (2011).

Related Content

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018
Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the...
Cardiva Medical Announces $41 Million for AMBULATE Vascular Closure Device Trial
News | Vascular Closure Devices | February 21, 2018
Vascular closure device provider Cardiva Medical announced that the company has closed on $11 million in additional...
The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomi
Vivasure Enrolls First Patient in Frontier IV Clinical Trial
News | Vascular Closure Devices | December 29, 2017
Vivasure Medical announced in October the successful enrollment of the first patient in the Frontier IV clinical study...
Enrollment Completed in U.S. IDE Trial for Manta Large Bore Vascular Closure Device
News | Vascular Closure Devices | December 22, 2017
Essential Medical announced the completion of enrollment in the U.S. pivotal investigational device exemption (IDE)...
Vasorum Launches Celt ACD Second-Generation Vascular Closure Device in the U.S.
Technology | Vascular Closure Devices | December 14, 2017
Vasorum Ltd, the developer and manufacturer of the novel Celt ACD vascular closure device, has added a 7F-sized Celt...
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices | October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices | September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.
Overlay Init